deCODE biostructures Initiates Research Collaboration with Genus Onocology

News Jun 22, 2007

deCODE biostructures, Inc. has announced the signing of a collaborative research agreement with Genus Oncology, LLC.

Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology. The research and milestone-based collaboration provides Genus Oncology with access to deCODE’s expertise in de novo protein crystal structure determination, from the engineering of synthetic genes to the determination of high resolution crystal structures.

Human Cell Atlas Study Sheds Light on Maternal-Fetal Interface

News

The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free